by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Dabur India Limited Warning Letter Details

Warning Letter

Dabur India Limited

Dabur India Limited, Dabur Corporate Office, Kaushambi Sahibabad Ghaziabad 201010 India

Issue DateJuly 24, 2026

FEI Number3001413302

Violations4

CountryIndia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Dabur India Limited FDA Warning Letter, July 24, 2026